Multicenter, Randomized, Active Comparator-Controlled, Double-Blind, Double-Dummy, Parallel Group, Dose-Finding Phase 2 Study Comparing the Safety of the Oral FXIa Inhibitor Asundexian with Apixaban in Patients with Atrial Fibrillation

Jonathan P Piccini, Valeria Caso, Stuart J Connolly, Keith A A Fox, Jonas Oldgren, Schuyler Jones, Diana Gorog, Vaclav Durdil, Thomas Viethen, Christoph Neumann, Hardi Mundl, Manesh R Patel

Research output: Contribution to journalArticlepeer-review

27 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Multicenter, Randomized, Active Comparator-Controlled, Double-Blind, Double-Dummy, Parallel Group, Dose-Finding Phase 2 Study Comparing the Safety of the Oral FXIa Inhibitor Asundexian with Apixaban in Patients with Atrial Fibrillation'. Together they form a unique fingerprint.

Medicine & Life Sciences